Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizing Muscle Relaxants
Launched by UNIVERSITY HOSPITAL OF SPLIT · Apr 30, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how much blood children lose during a common surgery called adenotonsillectomy, which involves removing the tonsils and adenoids. The researchers want to find out if using a specific type of muscle relaxant during anesthesia affects the amount of blood lost during the operation and afterward. The goal is to compare blood loss in two groups of children aged 3 to 7 years who will undergo this surgery.
To be part of this study, children need to be generally healthy and have no serious medical issues that would prevent them from receiving anesthesia. They'll be randomly assigned to one of the two groups, and during the trial, their blood loss will be carefully monitored. This research is important because it aims to improve our understanding of how to make surgeries safer for children and reduce complications related to blood loss. If you are considering this trial for your child, rest assured that it is designed with their safety in mind.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • conventional cold tonsillectomy and curettage adenoidectomy
- • American Society of Anesthesiologists (ASA) physical status classification system: I, II aged between 3 and 7 years
- Exclusion Criteria:
- • Contraindications for general anesthesia, coagulation disorders, anemia,identification of an infection during systemic examinations
About University Hospital Of Split
The University Hospital of Split, a leading medical institution in Croatia, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent academic hospital affiliated with the University of Split, it combines cutting-edge medical practices with rigorous scientific inquiry. The institution specializes in a wide range of medical fields, fostering collaborations among healthcare professionals, researchers, and educators. With a commitment to improving patient outcomes and contributing to the global medical community, the University Hospital of Split plays a pivotal role in the development of new therapies and treatment protocols through its robust clinical trial programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Split, , Croatia
Patients applied
Trial Officials
Ines Petrović
Principal Investigator
University Hospital Split, Department of Anesthesiology and Intensive Care, Split, Croatia
Ivan Vukovic
Study Chair
University Hospital Split, Department of Anesthesiology and Intensive Care, Split, Croatia
Benjamin Benzon
Study Chair
University of Split School of Medicine, Split, Croatia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported